Portfolio company
Hedera
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
6 investors
Sectors
About
This company develops in-house liquid biopsy tests and genomic analysis software for hospital laboratories to improve oncology care and patient outcomes.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hedera Dx
This company develops blood-based liquid biopsy tests and software for hospital laboratories to perform in-house molecular cancer diagnostics for patients.
Avant Genomics
The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.
Infiniplex
This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Predicta Biosciences
This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.
Oncoliq
This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.
Enumera Molecular
The company develops genomic analysis platforms and workflows for clinical laboratories to perform rapid and cost-effective liquid biopsy and diagnostic testing.
